Patentability. 1. Subject to the provisions of paragraphs 2 and 3 of this Article, patents shall be available for any inventions, whether products or processes, in all fields of technology, provided that they are new, involve an inventive step, and are capable of industrial application.
Patentability. LICENSEE acknowledges and agrees that the Licensed Technology is provided “AS IS” and it has and shall continue to rely exclusively upon its own diligent inquiries and assessments of the patentability of the Licensed Invention, the freedom to operate analysis for the Licensed Technology and the Licensed Products, and to determine the commercial potential thereof.
Patentability organoids, due to their innovative nature and potential applications in drug testing, disease modeling, and personalized medicine, can be patented. However, the patenting process must navigate ethical and legal boundaries set by EU regulations, particularly concerning the origin of the biological material and the rights of the original donors.
Patentability. Clear patent strategy Earliest time to exercise the option will be 15 months after the collaboration started. Project Agreement Neurosciences Victoria Ltd and Prana Biotechnology Ltd -------------------------------------------------------------------------------- Schedule 2 Project Management Committee -------------------------------------------------------------------------------- Project Management Committee for Project described in Appendix 2.2i of the RCA and entitled AB binding ligands for imaging of Alzheimer's Disease (AD)
Patentability. Lim its Defmed in A rticle 27
Patentability. Seller has perpetrated no fraud or deception in the filing and prosecution of the Patent Application. To the knowledge of Seller, the Device does not infringe on the rights of any other Person, whether as a violation of a patent or trade secret. Seller will immediately notify Purchaser of any infringement or suspected infringement on the Patent Application or the Patent, if it issues. Seller is the sole owner of the Patent Application and the technology evidenced thereby and no other Person has any rights or claims to the Patent Application or the technology disclosed therein. Seller's Patent Application was timely filed under U.S. patent laws and the rules of the United States Patent and Trademark Office, and there are no claims against Seller with respect thereto.
Patentability. TPP signatories shall ensure patents are available for any inventions (both products and processes) which are new, involve inventive step and capable of industrial application.
Patentability. The generally accepted requirements for granting the patent for an invention are novelty, inventive step and industrial application. Article 27 (1) of the TRIPS A greem ent reiterates the same criteria. But, the Agreement does not 243 A rticle 6 (g ), A rgentinean Palcnl Act. 244 A rticle IX , law 9 . 279 , 1996. 245 Para 4 o f the B ill. 165 I provide any definition o f those requirements. This gives the member countries some degree o f flexibility. According to the dominant practice an invention should be new in absolute terms in order to qualify for patent protection. The absolute novelty demands that the invention should not be past or prior art in any part o f the world. However, the US practice varies. In the US, novelty will not be lost when invention is divulged in non written means such as public use and sale. This concept o f relative novelty resulted in the patenting o f many kinds of traditional knowledge for example, patent on turmeric. According to the European practice, novelty is lost when any disclosure whether oral, written or by any other means is made in a foreign country. The developing countries can safeguard its interest by adopting the following measures.^'*’
Patentability. With respect to Patents, to the best of the knowledge of Organogenesis as at the Effective Date there exists no publication or other reason that would adversely affect the patentability of the subject matter or the validity of its Patents. It has no information as of the Effective Date to indicate that any entity licensed hereunder by it with respect to its Patents would not be free to make, use and sell Product or Product in the Territory without infringing any third party patent.
